Rekah Pharmaceutical Industry Ltd banner
R

Rekah Pharmaceutical Industry Ltd
TASE:REKA

Watchlist Manager
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Watchlist
Price: 1 182 ILS 0.6%
Market Cap: ₪139.9m

Profitability Summary

Rekah Pharmaceutical Industry Ltd's profitability score is 40/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

40/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

40/100
Profitability
Score
40/100
Profitability
Score

Margins

Earnings Waterfall
Rekah Pharmaceutical Industry Ltd

Margins Comparison
Rekah Pharmaceutical Industry Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
IL
Rekah Pharmaceutical Industry Ltd
TASE:REKA
139.1m ILS
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Rekah Pharmaceutical Industry Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
IL
Rekah Pharmaceutical Industry Ltd
TASE:REKA
139.1m ILS
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
930.7B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
581.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
256.9B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
233.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
222.2B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
286.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.1B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
118.9B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Rekah Pharmaceutical Industry Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett